Skip to main content
Clinical Trials/CTRI/2024/03/064877
CTRI/2024/03/064877
Not yet recruiting
Phase 4

A Randomised Control Trial to compare efficacy of Terlipressin plus Albumin vs Midodrine, Octreotide plus Albumin in the Treatment of Hepatorenal Syndrome . - Nil

Ananya Sharma0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K767- Hepatorenal syndrome
Sponsor
Ananya Sharma
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Ananya Sharma

Eligibility Criteria

Inclusion Criteria

  • 1\)Patient 18 years or older of both sexes
  • 2\)Patients diagnosed with HRS

Exclusion Criteria

  • 1\)Contraindications to Terlipressin
  • 2\)Patients diagnosed with chronic kidney disease
  • 3\)Child Pugh Score more than 13
  • 4\)Ongoing shock or uncontrolled bacterial infection
  • 5\)Current or recent treatment with nephrotoxic drugs
  • 6\)Presence of cardiovascular diseases and any extra hepatic diseases that could affect the short term prognosis

Outcomes

Primary Outcomes

Not specified

Similar Trials